{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:58:17Z","timestamp":1787029097264,"version":"build-2736575974"},"reference-count":79,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Katz Foundation"},{"name":"Ginsburg Foundation to A.O.S"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Arginases are often overexpressed in human diseases, and they are an important target for developing anti-aging and antineoplastic drugs. Arginase type 1 (ARG1) is a cytosolic enzyme, and arginase type 2 (ARG2) is a mitochondrial one. In this study, a dataset containing 2115-FDA-approved drug molecules is virtually screened for potential arginase binding using molecular docking against several ARG1 and ARG2 structures. The potential arginase ligands are classified into three categories: (1) Non-selective, (2) ARG1 selective, and (3) ARG2 selective. The evaluated potential arginase ligands are then compared with their clinical use. Remarkably, half of the top 30 potential drugs are used clinically to lower blood pressure and treat cancer, infection, kidney disease, and Parkinson\u2019s disease thus partially validating our virtual screen. Most notable are the antihypertensive drugs candesartan, irbesartan, indapamide, and amiloride, the antiemetic rolapitant, the anti-angina ivabradine, and the antidiabetic metformin which have minimal side effects. The partial validation also favors the idea that the other half of the top 30 potential drugs could be used in therapeutic settings. The three categories greatly expand the selectivity of arginase inhibition.<\/jats:p>","DOI":"10.3390\/molecules27165134","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:33:20Z","timestamp":1660534400000},"page":"5134","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6951-956X","authenticated-orcid":false,"given":"Trishna Saha","family":"Detroja","sequence":"first","affiliation":[{"name":"The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-3515","authenticated-orcid":false,"given":"Abraham O.","family":"Samson","sequence":"additional","affiliation":[{"name":"The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine Metabolism: Nitric Oxide and Beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/abbi.1994.1276","article-title":"Rat Liver Arginase: Kinetic Mechanism, Alternate Substrates, and Inhibitors","volume":"312","author":"Reczkowski","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1471-4159.1977.tb07783.x","article-title":"Arginases Of Mouse Brain And Liver","volume":"29","author":"Stewart","year":"1977","journal-title":"J. Neurochem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1152\/physrev.00037.2016","article-title":"Arginase: A Multifaceted Enzyme Important in Health and Disease","volume":"98","author":"Caldwell","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2483","DOI":"10.1038\/cddis.2016.295","article-title":"Arginase 2 Promotes Neurovascular Degeneration during Ischemia\/Reperfusion Injury","volume":"7","author":"Shosha","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exger.2018.12.011","article-title":"The Role of Arginase in Aging: A Systematic Review","volume":"116","author":"Moretto","year":"2019","journal-title":"Exp. Gerontol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"H777","DOI":"10.1152\/ajpheart.00831.2010","article-title":"Arginase 1 Contributes to Diminished Coronary Arteriolar Dilation in Patients with Diabetes","volume":"300","author":"Beleznai","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s13670-013-0060-7","article-title":"Functions and Mechanisms of Arginase in Age-Associated Cardiovascular Diseases","volume":"2","author":"Ming","year":"2013","journal-title":"Curr. Transl. Geriatr. Exp. Gerontol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0305-0491(95)02138-8","article-title":"Comparative Properties of Arginases","volume":"114","author":"Jenkinson","year":"1996","journal-title":"Comp. Biochem. Physiol. B. Biochem. Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/bj2700697","article-title":"Expression of Human Liver Arginase in Escherichia Coli. Purification and Properties of the Product","volume":"270","author":"Ikemoto","year":"1990","journal-title":"Biochem. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-1119(97)00099-1","article-title":"Human Type II Arginase: Sequence Analysis and Tissue-Specific Expression","volume":"193","author":"Morris","year":"1997","journal-title":"Gene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1152\/japplphysiol.90627.2008","article-title":"Arginase and Vascular Aging","volume":"105","author":"Santhanam","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fimmu.2017.00093","article-title":"Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity","volume":"8","author":"Rodriguez","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3858\/emm.2012.44.10.068","article-title":"Increased Arginase II Activity Contributes to Endothelial Dysfunction through Endothelial Nitric Oxide Synthase Uncoupling in Aged Mice","volume":"44","author":"Shin","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"112840","DOI":"10.1016\/j.biopha.2022.112840","article-title":"Arginase: An Emerging and Promising Therapeutic Target for Cancer Treatment","volume":"149","author":"Niu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered Arginine Metabolism in Alzheimer\u2019s Disease Brains","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3233\/JAD-2010-100630","article-title":"Is the Urea Cycle Involved in Alzheimer\u2019s Disease?","volume":"21","author":"Hansmannel","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbadis.2016.03.001","article-title":"Graded Perturbations of Metabolism in Multiple Regions of Human Brain in Alzheimer\u2019s Disease: Snapshot of a Pervasive Metabolic Disorder","volume":"1862","author":"Xu","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E11293","DOI":"10.1073\/pnas.1711243115","article-title":"Brain Urea Increase Is an Early Huntington\u2019s Disease Pathogenic Event Observed in a Prodromal Transgenic Sheep Model and HD Cases","volume":"114","author":"Handley","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fimmu.2013.00111","article-title":"Role of Arginase in Vessel Wall Remodeling","volume":"4","author":"Durante","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-30-95","article-title":"The Mechanisms by Which Polyamines Accelerate Tumor Spread","volume":"30","author":"Soda","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1152\/japplphysiol.91393.2008","article-title":"Arginase Inhibition Restores NOS Coupling and Reverses Endothelial Dysfunction and Vascular Stiffness in Old Rats","volume":"107","author":"Jae","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1113\/JP270538","article-title":"Ageing, Metabolism and Cardiovascular Disease","volume":"594","author":"Costantino","year":"2016","journal-title":"J. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/HJH.0b013e3282fcc357","article-title":"Treatment with the Arginase Inhibitor N\u03c9-Hydroxy-nor-L-Arginine Improves Vascular Function and Lowers Blood Pressure in Adult Spontaneously Hypertensive Rat","volume":"26","author":"Bagnost","year":"2008","journal-title":"J. Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/01.hjh.0000166837.78559.93","article-title":"Arginase Inhibition Reduces Endothelial Dysfunction and Blood Pressure Rising in Spontaneously Hypertensive Rats","volume":"23","author":"Demougeot","year":"2005","journal-title":"J. Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-14-1491","article-title":"L-Arginine Depletion Blunts Antitumor T-Cell Responses by Inducing Myeloid-Derived Suppressor Cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Munder, M., Engelhardt, M., Knies, D., Medenhoff, S., Wabnitz, G., Luckner-Minden, C., Feldmeyer, N., Voss, R.H., Kropf, P., and M\u00fcller, I. (2013). Cytotoxicity of Tumor Antigen Specific Human T Cells Is Unimpaired by Arginine Depletion. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063521"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/MTOR Signaling in Cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.celrep.2014.09.046","article-title":"Expression Quantitative Trait Loci and Receptor Pharmacology Implicate Arg1 and the GABA-A Receptor as Therapeutic Targets in Neuroblastoma","volume":"9","author":"Hackett","year":"2014","journal-title":"Cell. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Atawia, R.T., Toque, H.A., Meghil, M.M., Benson, T.W., Yiew, N.K.H., Cutler, C.W., Weintraub, N.L., Caldwell, R.B., and Caldwell, R.W. (2019). Role of Arginase 2 in Systemic Metabolic Activity and Adipose Tissue Fatty Acid Metabolism in Diet-Induced Obese Mice. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061462"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e000096","DOI":"10.1161\/JAHA.113.000096","article-title":"Arginase-II Induces Vascular Smooth Muscle Cell Senescence and Apoptosis through P66Shc and P53 Independently of Its l-Arginine Ureahydrolase Activity: Implications for Atherosclerotic Plaque Vulnerability","volume":"2","author":"Xiong","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/acel.12001","article-title":"Positive Crosstalk between Arginase-II and S6K1 in Vascular Endothelial Inflammation and Aging","volume":"11","author":"Yepuri","year":"2012","journal-title":"Aging Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvp277","article-title":"Arginase Contributes to Endothelial Cell Oxidative Stress in Response to Plasma from Women with Preeclampsia","volume":"85","author":"Sankaralingam","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4236\/aad.2018.74009","article-title":"Arginase as a Potential Target in the Treatment of Alzheimer\u2019s Disease","volume":"7","author":"Polis","year":"2018","journal-title":"Adv. Alzheimer\u2019s Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Polis, B., Srikanth, K.D., Gurevich, V., Bloch, N., Gil-Henn, H., and Samson, A.O. (2020). Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer\u2019s Disease Mice. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031133"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s11064-021-03519-3","article-title":"Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer\u2019s Disease Mice","volume":"47","author":"Polis","year":"2022","journal-title":"Neurochem. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/med.21419","article-title":"Arginase Inhibitors: A Rational Approach Over One Century","volume":"37","author":"Pudlo","year":"2017","journal-title":"Med. Res. Rev."},{"key":"ref_38","first-page":"647","article-title":"Investigation of Mammal Arginase Inhibitory Properties of Natural Ubiquitous Polyphenols by Using an Optimized Colorimetric Microplate Assay","volume":"83","author":"Bordage","year":"2017","journal-title":"Planta Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1039\/D0MD00011F","article-title":"Synthesis, Evaluation and Molecular Modelling of Piceatannol Analogues as Arginase Inhibitors","volume":"11","author":"Muller","year":"2020","journal-title":"RSC Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s12272-013-0125-3","article-title":"Arginase II Inhibitory Activity of Flavonoid Compounds from Scutellaria Indica","volume":"36","author":"Kim","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Pham, T.N., Bordage, S., Pudlo, M., Demougeot, C., Thai, K.M., and Girard-Thernier, C. (2016). Cinnamide Derivatives as Mammalian Arginase Inhibitors: Synthesis, Biological Evaluation and Molecular Docking. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101656"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s13311-018-0669-5","article-title":"L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer\u2019s Disease","volume":"15","author":"Polis","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A.T., Clement, M., Dussiot, M., Levillain, O., Graff-Dubois, S., and Nicoletti, A. (2010). Macrophage Plasticity in Experimental Atherosclerosis. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008852"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2011.06.025","article-title":"Arginase I Deficiency: Severe Infantile Presentation with Hyperammonemia: More Common than Reported?","volume":"104","author":"Nagamani","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pediatrneurol.2009.07.017","article-title":"Diffusion Tensor Imaging in Arginase Deficiency Reveals Damage to Corticospinal Tracts","volume":"42","author":"Oldham","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1128\/MCB.22.13.4491-4498.2002","article-title":"Mouse Model for Human Arginase Deficiency","volume":"22","author":"Iyer","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.18632\/aging.100722","article-title":"Role of P38 Mitogen-Activated Protein Kinase in Vascular Endothelial Aging: Interaction with Arginase-II and S6K1 Signaling Pathway","volume":"7","author":"Wu","year":"2015","journal-title":"Aging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e000992","DOI":"10.1161\/JAHA.112.000992","article-title":"Arginase II Promotes Macrophage Inflammatory Responses Through Mitochondrial Reactive Oxygen Species, Contributing to Insulin Resistance and Atherogenesis","volume":"1","author":"Ming","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"F899","DOI":"10.1152\/ajprenal.00158.2017","article-title":"Distinct Roles of Arginases 1 and 2 in Diabetic Nephropathy","volume":"313","author":"Morris","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/HYPERTENSIONAHA.108.121731","article-title":"Arginase II Knockout Mouse Displays a Hypertensive Phenotype despite a Decreased Vasoconstrictory Profile","volume":"54","author":"Huynh","year":"2009","journal-title":"Hypertension"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fphys.2017.00682","article-title":"Arginase-II Deficiency Extends Lifespan in Mice","volume":"8","author":"Xiong","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymgme.2003.10.012","article-title":"Arginases I and II: Do Their Functions Overlap?","volume":"81","author":"Cederbaum","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2147\/DDDT.S133127","article-title":"Virtual Screening for Potential Inhibitors of Mcl-1 Conformations Sampled by Normal Modes, Molecular Dynamics, and Nuclear Magnetic Resonance","volume":"11","author":"Meirson","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2147\/DDDT.S136150","article-title":"An in Silico High-Throughput Screen Identifies Potential Selective Inhibitors for the Non-Receptor Tyrosine Kinase Pyk2","volume":"11","author":"Meirson","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15\u2014Ligand Discovery for Everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_56","first-page":"1","article-title":"Open Babel: An Open Chemical Toolbox","volume":"3","author":"Banck","year":"2011","journal-title":"J. Cheminform."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization and Multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1021\/jm400014c","article-title":"Discovery of (R)-2-Amino-6-Borono-2-(2-(Piperidin-1-Yl)Ethyl)Hexanoic Acid and Congeners as Highly Potent Inhibitors of Human Arginases i and II for Treatment of Myocardial Reperfusion Injury","volume":"56","author":"Whitehouse","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1021\/jm200443b","article-title":"Binding of \u03b1,\u03b1-Disubstituted Amino Acids to Arginase Suggests New Avenues for Inhibitor Design","volume":"54","author":"Ilies","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1016\/j.bmcl.2013.06.092","article-title":"Synthesis of Quaternary \u03b1-Amino Acid-Based Arginase Inhibitors via the Ugi Reaction","volume":"23","author":"Golebiowski","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_62","unstructured":"Schr\u00f6dinger, L.L.C. (2015). The {PyMOL} Molecular Graphics System, Schr\u00f6dinger. Version~1.8."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: Expanding the Scope of the Protein\u2013Ligand Interaction Profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"044130","DOI":"10.1063\/5.0014475","article-title":"Scalable Molecular Dynamics on CPU and GPU Architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J. Chem. Phys."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: A Web-Based Graphical User Interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: An Improved Force Field for Folded and Intrinsically Disordered Proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual Molecular Dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/jcc.24829","article-title":"CHARMM-GUI Ligand Reader & Modeler for CHARMM Force Field Generation of Small Molecules","volume":"38","author":"Kim","year":"2017","journal-title":"J. Comput. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/ci300506y","article-title":"Impact of Substrate Protonation and Tautomerization States on Interactions with the Active Site of Arginase I","volume":"53","author":"Nagagarajan","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of Simple Potential Functions for Simulating Liquid Water","volume":"79","author":"Jorgensen","year":"1998","journal-title":"J. Chem. Phys."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM General Force Field: A Force Field for Drug-like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/jcc.23067","article-title":"Extension of the CHARMM General Force Field to Sulfonyl-Containing Compounds and Its Utility in Biomolecular Simulations","volume":"33","author":"Yu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A Smooth Particle Mesh Ewald Method","volume":"103","author":"Essmann","year":"1998","journal-title":"J. Chem. Phys."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1021\/bi010783g","article-title":"Classical and Slow-Binding Inhibitors of Human Type II Arginase","volume":"40","author":"Colleluori","year":"2001","journal-title":"Biochemistry"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2010.02.004","article-title":"Inhibition of Human Arginase I by Substrate and Product Analogues","volume":"496","author":"Ilies","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-1241.2011.02633.x","article-title":"Comparative Clinical- and Cost-Effectiveness of Candesartan and Losartan in the Management of Hypertension and Heart Failure: A Systematic Review, Meta- and Cost-Utility Analysis","volume":"65","author":"Grosso","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1592\/phco.28.3.366","article-title":"Effects of Antihypertensive Drug Treatment on the Risk of Dementia and Cognitive Impairment","volume":"28","author":"Poon","year":"2008","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA Methods to Estimate Ligand-Binding Affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/16\/5134\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:07:35Z","timestamp":1760141255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/16\/5134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":79,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["molecules27165134"],"URL":"https:\/\/doi.org\/10.3390\/molecules27165134","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]}}}